These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16218468)

  • 21. Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype.
    Ahmad Y; Shelmerdine J; Bodill H; Lunt M; Pattrick MG; Teh LS; Bernstein RM; Walker MG; Bruce IN
    Rheumatology (Oxford); 2007 Jun; 46(6):983-8. PubMed ID: 17384179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accelerated atherosclerosis in patients with systemic autoimmune diseases.
    de Leeuw K; Kallenberg C; Bijl M
    Ann N Y Acad Sci; 2005 Jun; 1051():362-71. PubMed ID: 16126978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus].
    Serikova SIu; Kozlovskaia NL; Shilov EM
    Ter Arkh; 2008; 80(6):52-8. PubMed ID: 18655477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.
    Salmon JE; Roman MJ
    Am J Med; 2008 Oct; 121(10 Suppl 1):S3-8. PubMed ID: 18926167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accelerated atheroma in lupus--background.
    Urowitz MB; Gladman DD
    Lupus; 2000; 9(3):161-5. PubMed ID: 10805481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus.
    Liu Y; Yu X; Zhang W; Zhang X; Wang M; Ji F
    J Autoimmun; 2022 Oct; 132():102863. PubMed ID: 35853760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment.
    Ruiz-Limon P; Barbarroja N; Perez-Sanchez C; Aguirre MA; Bertolaccini ML; Khamashta MA; Rodriguez-Ariza A; Almadén Y; Segui P; Khraiwesh H; Gonzalez-Reyes JA; Villalba JM; Collantes-Estevez E; Cuadrado MJ; Lopez-Pedrera C
    Ann Rheum Dis; 2015 Jul; 74(7):1450-8. PubMed ID: 24658835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of autoimmune neutropenia in Felty's syndrome and systemic lupus erythematosus.
    Newman KA; Akhtari M
    Autoimmun Rev; 2011 May; 10(7):432-7. PubMed ID: 21255689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The problem of accelerated atherosclerosis in systemic lupus erythematosus: insights into a complex co-morbidity.
    Wade NS; Major AS
    Thromb Haemost; 2011 Nov; 106(5):849-57. PubMed ID: 21979131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4+CXCR3+ T cells and plasmacytoid dendritic cells drive accelerated atherosclerosis associated with systemic lupus erythematosus.
    Clement M; Charles N; Escoubet B; Guedj K; Chauveheid MP; Caligiuri G; Nicoletti A; Papo T; Sacre K
    J Autoimmun; 2015 Sep; 63():59-67. PubMed ID: 26183767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
    Sarzi-Puttini P; Atzeni F; Carrabba M
    Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accelerated atherosclerosis in patients with systemic lupus erythematosus: a review of the causes and possible prevention.
    Thomas GN; Tam LS; Tomlinson B; Li EK
    Hong Kong Med J; 2002 Feb; 8(1):26-32. PubMed ID: 11861990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus: understanding management strategies.
    Turano L
    J Cardiovasc Nurs; 2013; 28(1):48-53. PubMed ID: 22210142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment of patients with systemic lupus erythematosus complicated with autoimmune thyroid disease using double-filtration plasmapheresis: a retrospective study.
    Liu LL; Li XL; Wang LN; Yao L; Fan QL; Li ZL
    J Clin Apher; 2011; 26(4):174-80. PubMed ID: 21462239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Where the immune response meets the vessel wall.
    Bisoendial RJ; Stroes ES; Tak PP
    Neth J Med; 2009 Sep; 67(8):328-33. PubMed ID: 19767659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The latest in systemic lupus erythematosus-accelerated atherosclerosis: related mechanisms inform assessment and therapy.
    Appleton BD; Major AS
    Curr Opin Rheumatol; 2021 Mar; 33(2):211-218. PubMed ID: 33394753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: a literature review.
    Benvenuti F; Gatto M; Larosa M; Iaccarino L; Punzi L; Doria A
    Expert Opin Drug Saf; 2015; 14(9):1373-85. PubMed ID: 26212119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [High cardiovascular complications in systemic lupus erythematosus: physiopathology and risk management].
    Boffa JJ; Rougier JP; Noël N; Ronco P
    Nephrol Ther; 2009 Dec; 5(7):595-602. PubMed ID: 19733524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accelerated atherosclerosis, immune response and autoimmune rheumatic diseases.
    Jara LJ; Medina G; Vera-Lastra O; Amigo MC
    Autoimmun Rev; 2006 Mar; 5(3):195-201. PubMed ID: 16483919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atherosclerosis is accelerated in patients with long-term well-controlled systemic lupus erythematosus (SLE).
    Sato H; Miida T; Wada Y; Maruyama M; Murakami S; Hasegawa H; Kuroda T; Narita I; Nakano M; Gejyo F
    Clin Chim Acta; 2007 Oct; 385(1-2):35-42. PubMed ID: 17644082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.